Medartis Holding AG (MDRSF)
USD 66.68
(0.0%)
USD 66.68
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 112.33 Million CHF | 15.27% |
| 2022 | 97.44 Million USD | 19.84% |
| 2021 | 81.31 Million USD | 3.04% |
| 2020 | 78.91 Million USD | 4.77% |
| 2019 | 75.32 Million USD | 100.48% |
| 2018 | 37.57 Million CHF | -66.88% |
| 2017 | 113.45 Million CHF | 15.6% |
| 2016 | 98.14 Million CHF | -34.56% |
| 2015 | 149.97 Million CHF | -1.51% |
| 2014 | 152.27 Million CHF | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 191.95 Million CHF | 70.88% |
| 2024 Q2 | 191.95 Million CHF | 0.0% |
| 2023 Q3 | 94.57 Million CHF | -5.76% |
| 2023 Q1 | 89.86 Million CHF | -7.78% |
| 2023 FY | 112.33 Million CHF | 15.27% |
| 2023 Q4 | 112.33 Million CHF | 18.77% |
| 2023 Q2 | 100.35 Million USD | 11.67% |
| 2022 Q1 | 98.13 Million CHF | 32.29% |
| 2022 Q3 | 90.11 Million CHF | -0.62% |
| 2022 Q4 | 97.44 Million USD | 8.14% |
| 2022 FY | 97.44 Million USD | 19.84% |
| 2022 Q2 | 90.68 Million CHF | -7.59% |
| 2021 Q1 | 76.86 Million CHF | 10.19% |
| 2021 FY | 81.31 Million USD | 3.04% |
| 2021 Q4 | 74.18 Million CHF | -6.82% |
| 2021 Q3 | 79.61 Million CHF | 9.6% |
| 2021 Q2 | 72.63 Million CHF | -5.5% |
| 2020 FY | 78.91 Million USD | 4.77% |
| 2020 Q4 | 69.75 Million CHF | -7.88% |
| 2020 Q3 | 75.72 Million CHF | 10.96% |
| 2020 Q2 | 68.24 Million CHF | -3.76% |
| 2020 Q1 | 70.9 Million CHF | -2.78% |
| 2019 Q4 | 72.93 Million CHF | -0.2% |
| 2019 Q2 | 66.18 Million CHF | 2.12% |
| 2019 Q1 | 64.81 Million CHF | 72.51% |
| 2019 FY | 75.32 Million USD | 100.48% |
| 2019 Q3 | 73.08 Million CHF | 10.42% |
| 2018 Q1 | 43.25 Million CHF | -61.87% |
| 2018 FY | 37.57 Million CHF | -66.88% |
| 2018 Q3 | 38.28 Million CHF | -7.26% |
| 2018 Q2 | 41.27 Million CHF | -4.58% |
| 2018 Q4 | 37.57 Million CHF | -1.85% |
| 2017 Q3 | 117.17 Million CHF | 0.0% |
| 2017 FY | 113.45 Million CHF | 15.6% |
| 2017 Q4 | 113.45 Million CHF | -3.18% |
| 2017 Q1 | - CHF | 0.0% |
| 2016 FY | 98.14 Million CHF | -34.56% |
| 2015 FY | 149.97 Million CHF | -1.51% |
| 2014 FY | 152.27 Million CHF | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | -465.458% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -5203.612% |
| Össur hf. | 688.8 Million USD | 83.692% |
| QHSLab, Inc. | 2.05 Million USD | -5360.76% |
| Wellstar International, Inc. | 55.99 Million USD | -100.624% |
| Össur hf. | 688.8 Million USD | 83.692% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -3709.954% |
| Aurora Spine Corporation | 6.65 Million USD | -1588.283% |
| BrainsWay Ltd. | 15.31 Million USD | -633.515% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | -575.761% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -145.034% |
| Vivos Inc. | 245 Thousand USD | -45748.439% |
| Kelyniam Global, Inc. | 1.01 Million USD | -10989.607% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -40656.46% |
| Zecotek Photonics Inc. | 5.86 Million USD | -1814.092% |
| Avitar, Inc. | 11.59 Million USD | -868.906% |
| Nanomix Corporation | 14.81 Million USD | -658.234% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -598.55% |
| Theraclion SA | 13.01 Million EUR | -762.981% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | -5444.453% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -3002.05% |
| Lombard Medical, Inc. | 53.79 Million USD | -108.816% |
| ALR Technologies Inc. | 24.5 Million USD | -358.392% |
| Stratec SE | 271.97 Million USD | 58.698% |
| Vycor Medical, Inc. | 4.31 Million USD | -2501.584% |
| Heart Tronics, Inc. | 1.09 Million USD | -10160.471% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 95.482% |
| VMS Rehab Systems, Inc. | 201.36 USD | -55785810.807% |
| NewCardio, Inc. | 6.01 Million USD | -1768.237% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -1951.699% |
| Ingen Technologies, Inc. | 5.7 Million USD | -1867.415% |
| Odyssey Group International, Inc. | 6.61 Million USD | -1598.96% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -4485.278% |
| Wellness Center USA, Inc. | 5.12 Million USD | -2092.158% |
| SANUWAVE Health, Inc. | 65.59 Million USD | -71.251% |
| IR-Med Inc. | 634 Thousand USD | -17617.746% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -1951.112% |
| Polarean Imaging plc | 2.58 Million USD | -4252.986% |
| United American Healthcare Corporation | 119 Thousand USD | -94295.387% |
| ECGI Holdings, Inc. | 11.94 Million USD | -840.763% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -4662.217% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -8384.28% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -7666.552% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -16477.311% |
| Urologix, Inc. | 12.64 Million USD | -788.41% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -1981.712% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -1224.269% |
| SS Innovations International, Inc. | 11.18 Million USD | -904.646% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -21280.527% |
| Smith & Nephew plc | 4.76 Billion USD | 97.642% |
| NIOX Group Plc | 9.8 Million USD | -1045.984% |
| Fuse Medical, Inc. | 15.11 Million USD | -643.415% |
| Broncus Holding Corporation | 10.43 Million USD | -976.771% |
| Brain Scientific Inc. | 7.42 Million USD | -1412.583% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -232.304% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -14045.976% |